What Makes an Oligonucleotide Therapeutic Different from Traditional Drugs?

A unique characteristic of oligonucleotide-based drugs is that they can act on the root-cause of diseases, instead of treating just symptoms. Traditional drugs act on proteins – the end products of genetic information. Oligonucleotide therapeutics act earlier, at the genetic level where disease causing proteins are made.

Targeting the Root Cause

By binding to specific sequences of RNA or DNA, oligonucleotides can silence, correct, or modulate genetic messages. This allows scientists to directly influence how genes behave – an approach that’s both precise and adaptable.

For example:

• Antisense oligonucleotides (ASOs) block faulty RNA messages or modulate switching to restore or alter protein function
• siRNA molecules promote selective degradation of target RNA through the RNA interference pathway
• Guide RNAs direct complex gene editing machineries like CRISPR/Cas9 to their target sequence

Why this matters

The unmatched level of precision enables the development of treatments for diseases that were once beyond reach – from rare genetic disorders to cancer and neurological conditions. In many cases, a single treatment over the course of a lifetime can address the underlying cause of a disease. 

A Different Kind of Drug Requires a Different Kind of Partner

Unlike many small molecules, oligonucleotides require specialized synthesis, purification, and analytical control. Sequence integrity, impurity profile, and chemical modifications can all influence product performance. That is why manufacturing and analytics are not just supporting functions in this field. They are central to product quality.With nearly three decades of experience, BioSpring provides the manufacturing and analytical excellence required to support bringing these therapies to patients safely and efficiently.

A New Paradigm in Medicine

Oligonucleotide therapeutics represent a transformative approach to medicine. By treating diseases at the source, they embody the next evolution in precision medicine.

At BioSpring, we’re proud to help turn these ideas into impact – moving the elements of life from molecules to medicine.